Potential physiological importance of pyrroloquinoline quinone

Alternative Medicine Review

Volumn 14, Issue 3, 2009, Pages 268-277

  Rucker, Robert ^a   Chowanadisai, Winyoo ^a   Nakano, Masahiko ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MITSUBISHI GAS CHEMICAL COMPANY INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYDOPA; ALPHA TOCOPHEROL; ASCORBIC ACID; CATECHIN; DOPA; EPICATECHIN; GLUTATHIONE; NORADRENALIN; PYRROLOQUINOLINE QUINONE; QUERCETIN; QUINONE DERIVATIVE; UBIDECARENONE; UNCLASSIFIED DRUG; URIC ACID;

ABSENCE OF SIDE EFFECTS; ANTIOXIDANT ACTIVITY; BACTERIUM; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CLINICAL TRIAL; COGNITION; DEVELOPMENT; DRUG MECHANISM; EDEMA; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; LEARNING DISORDER; LIVER TOXICITY; MEMORY DISORDER; MITOCHONDRIAL RESPIRATION; NONHUMAN; PLANT; RECOMMENDED DRUG DOSE; REPRODUCTION; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL PROLIFERATION; CHEMOTACTIC FACTORS; COGNITION; HEART DISEASES; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PQQ COFACTOR; SIGNAL TRANSDUCTION;

EID: 70350052853     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Hauge JG. Glucose dehydrogenase of Bacterium anitratum: an enzyme with a novel prosthetic group. J Biol Chem 1964;239:3630-3639.
2. Anthony C. Pyrroloquinoline quinone (PQQ) and quinoprotein enzymes. Antioxid Redox Signal 2001;3:757-774. (Pubitemid 33131268)
3. Anthony C, Williams P. The structure and mechanism of methanol dehydrogenase. Biochim Biophys Acta 2003;1647:18-23.
4. Goodwin PM, Anthony C. The biochemistry, physiology and genetics of PQQ and PQQ-containing enzymes. Adv Microb Physiol 1998;40:1-80. (Pubitemid 28537738)
5. Forrest HS, Salisbury SA, Sperl G. Crystallization of a derivative of a new coenzyme, methoxatin. Biochim Biophys Acta 1981;676:226-229.
6. Forrest HS, Salisbury SA, Kilty CG. A mechanism for the enzymatic oxidation of methanol involving methoxatin. Biochem Biophys Res Commun 1980;97:248-251.
7. Duine JA. Cofactor diversity in biological oxidations: implications and applications. Chem Rec 2001;1:74-83.
8. Stites TE, Mitchell AE, Rucker RB. Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr 2000;130:719-727.
9. Paz MA, Martin P, Fluckiger R, et al. The catalysis of redox cycling by pyrroloquinoline quinone (PQQ), PQQ derivatives, and isomers and the specificity of inhibitors. Anal Biochem 1996;238:145-149. (Pubitemid 26234874)
10. Bishop A, Paz MA, Gallop PM, Karnovsky ML. Inhibition of redox cycling of methoxatin (PQQ), and of superoxide release by phagocytic white cells. Free Radic Biol Med 1995;18:617-620.
11. Fluckiger R, Paz MA, Gallop PM. Redox-cycling detection of dialyzable pyrroloquinoline quinone and quinoproteins. Methods Enzymol 1995;258:140-149.
12. Karnovsky ML, Bishop A, Camerero VC, et al. Aspects of the release of superoxide by leukocytes, and a means by which this is switched off. Environ Health Perspect 1994;102:43-44.
13. Paz MA, Fluckiger R, Gallop PM. Redox-cycling is a property of PQQ but not of ascorbate. FEBS Lett 1990;264:283-284. (Pubitemid 20169236)
14. Katz E, Willner I. A biofuel cell with electrochemically switchable and tunable power output. J Am Chem Soc 2003;125:6803-6813. (Pubitemid 36675358)
15. Mukherjee J, Lumibao CY, Kirchhoff JR. Application of a thiol-specific electrocatalytic electrode for real-time amperometric monitoring of enzymatic hydrolysis. Analyst 2009;134:582-586.
16. Willner I, Baron R, Willner B. Integrated nanoparticle-biomolecule systems for biosensing and bioelectronics. Biosens Bioelectron 2007;22:1841-1852. (Pubitemid 46349651)
17. Szeponik J, Möller B, Pfeiffer D, et al. Ultrasensitive bienzyme sensor for adrenaline. Biosens Bioelectron 1997;12:947-952.
18. Puehringer S, Metlitzky M, Schwarzenbacher R. The pyrroloquinoline quinone biosynthesis pathway revisited: a structural approach. BMC Biochem 2008;9:8.
19. Magnusson OT, RoseFigura JM, Toyama H, et al. Pyrroloquinoline quinone biogenesis: characterization of PqqC and its H84N and H84A active site variants. Biochemistry 2007;46:7174-7186. (Pubitemid 46973991)
20. Magnusson OT, Toyama H, Saeki M, et al. Quinone biogenesis: structure and mechanism of PqqC, the final catalyst in the production of pyrroloquinoline quinone. Proc Natl Acad Sci U S A 2004;101:7913-7918. (Pubitemid 38698028)
21. Krueger FR, Werther W, Kissel J, Schmid ER. Assignment of quinone derivatives as the main compound class composing 'interstellar' grains based on both polarity ions detected by the 'Cometary and Interstellar Dust Analyser' (CIDA) onboard the spacecraft STARDUST. Rapid Commun Mass Spectrom 2004;18:103-111.
22. Kissel J, Krueger FR, Silén J, Clark BC. The Cometary and Interstellar Dust Analyzer at comet 81P/Wild 2. Science 2004;304:1774-1776. (Pubitemid 38787888)
23. Choi O, Kim J, Kim JG, et al. Pyrroloquinoline quinone is a plant growth promotion factor produced by Pseudomonas fluorescens B16. Plant Physiol 2008;146:657-668. (Pubitemid 351230794)
24. Rodriguez H, Gonzalez T, Selman G. Expression of a mineral phosphate solubilizing gene from Erwinia herbicola in two rhizobacterial strains. J Biotechnol 2001;84:155-161. (Pubitemid 30821715)
25. Pierpoint WS. PQQ in plants. Trends Biochem Sci 1990;15:299.
26. Mitchell AE, Jones AD, Mercer RS, Rucker RB. Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal Biochem 1999;269:317-325.
27. Kumazawa T, Seno H, Suzuki O. Failure to verify high levels of pyrroloquinoline quinone in eggs and skim milk. Biochem Biophys Res Commun 1993;193:1-5. (Pubitemid 23199904)
28. Kumazawa T, Sato K, Seno H, et al. Levels of pyrroloquinoline quinone in various foods. Biochem J 1995;307:331-333.
29. Matsushita K, Arents JC, Bader R, et al. Escherichia coli is unable to produce pyrroloquinoline quinone (PQQ). Microbiology 1997;143:3149-3156. (Pubitemid 27470162)
30. Steinberg FM, Gershwin ME, Rucker RB. Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J Nutr 1994;124:744-753.
31. Steinberg F, Stites TE, Anderson P, et al. Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets. Exp Biol Med (Maywood) 2003;228:160-166. (Pubitemid 36187922)
32. Kasahara T, Kato T. Nutritional biochemistry: a new redox-cofactor vitamin for mammals. Nature 2003;422:832. (Pubitemid 36520027)
33. Rucker R, Storms D, Sheets A, et al. Biochemistry: is pyrroloquinoline quinone a vitamin? Nature 2005;433:E10-E11;discussion E11-E12.
34. Felton LM, Anthony C. Biochemistry: role of PQQ as a mammalian enzyme cofactor? Nature 2005;433:E10;discussion E11-E12.
35. Sato K, Toriyama M. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. J Dermatol Sci 2009;53:140-145.
36. Hirakawa A, Shimizu K, Fukumitsu H, Furukawa S. Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord. Biochem Biophys Res Commun 2009;378:308-312.
37. Nunome K, Miyazaki S, Nakano M, et al. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol Pharm Bull 2008;31:1321-1326. (Pubitemid 351930640)
38. Kumazawa T, Hiwasa T, Takiguchi M, et al. Activation of ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts. Int J Mol Med 2007;19:765-770.
39. Chowanadisai W, Bauerly K, Tchaparian E, Rucker RB. Pyrroloquinoline quinone (PQQ) stimulates mitochondrial biogenesis. FASEB J 2007;21:854.
40. Ouchi A, Nakano M, Nagaoka S, Mukai K. Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH(2), a reduced form of pyrroloquinolinequinone) in micellar solution. J Agric Food Chem 2009;57:450-456.
41. Stites T, Storms D, Bauerly K, et al. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 2006;136:390-396. (Pubitemid 43228291)
42. Bauerly KA, Storms DH, Harris CB, et al. Pyrroloquinoline quinone nutritional status alters lysine metabolism and modulates mitochondrial DNA content in the mouse and rat. Biochim Biophys Acta 2006;1760:1741-1748.
43. Zhu BQ, Simonis U, Cecchini G, et al. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovase Pharmacol Ther 2006;11:119-128. (Pubitemid 44449101)
44. Debray FG, Lambert M, Mitchell GA. Disorders of mitochondrial function. Curr Opin Pediatr 2008;20:471-482.
45. Puigserver P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obe (Lond) 2005;29:S5-S9. (Pubitemid 40343163)
46. Muoio DM, Koves TR. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC-1alpha: implications for metabolic disease. Appl Physiol Nutr Metab 2007;32:874-883.
47. Tsuchida T, Yasuyama T, Higuchi K, et al. The protective effect of pyrroloquinoline quinone and its derivatives against carbon tetrachloride- induced liver injury of rats. J Gastroenterol Hepatol 1993;8:342-347. (Pubitemid 23203400)
48. Urakami T, Yoshida C, Akaike T, et al. Synthesis of monoesters of pyrroloquinoline quinone and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivo. J Nutr Sci Vitaminol (Tokyo) 1997;43:19-33. (Pubitemid 27189654)
49. Hamagishi Y, Murata S, Kamei H, et al. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J Pharmacol Exp Ther 1990;255:980-985.
50. Naito Y, Kumazawa T, Kino I, Suzuki O. Effects of pyrroloquinoline quinone (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts. Life Sci 1993;52:1909-1915. (Pubitemid 23144901)
51. Aizenman E, Hartnett KA, Zhong C, et al. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J Neurosci 1992;12:2362-2369.
52. Zhang Y, Feustel PJ, Kimelberg HK. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res 2006;1094:200-206. (Pubitemid 43927615)
53. Zhang Y, Rosenberg PA. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci 2002;16:1015-1024. (Pubitemid 35463551)
54. Jensen FE, Gardner GJ, Williams AP, et al. The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience 1994;62:399-406.
55. Sanchez RM, Wang C, Gardner G, et al. Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J Neurosci 2000;20:2409-2417. (Pubitemid 30230093)
56. Scanlon JM, Aizenman E, Reynolds IJ. Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur J Pharmacol 1997;326:67-74. (Pubitemid 27205047)
57. Aizenman E, Jensen FE, Gallop PM, et al. Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci Lett 1994;168:189-192. (Pubitemid 24097354)
58. Zhang P, Xu Y, Sun J, et al. Protection of pyrroloquinoline quinone against methylmercury-induced neurotoxicity via reducing oxidative stress. Free Radic Res 2009;43:224-233.
59. Murase K, Hattori A, Kohno M, Hayashi K. Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem Mol Biol Int 1993;30:615-621. (Pubitemid 23250504)
60. Ohwada K, Takeda H, Yamazaki M, et al. Pyrroloquinoline quinone (PQQ) prevents cognitive deficit caused by oxidative stress in rats. J Clin Biochem Nutr 2008;42:29-34. (Pubitemid 351252893)
61. Tao R, Karliner JS, Simonis U, et al. Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem Biophys Res Commun 2007;363:257-262. (Pubitemid 47484323)
62. Zhu BQ, Zhou HZ, Teerlink JR, Karliner JS. Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther 2004;18:421-431.
63. Tsuji T, Yamaguchi K, Kondo K, Urakami T. Nerve growth factor production accelerators and compositions for preventing or treating neuronal degeneration. US Patent 5846977; 1998.
64. Urakami T. Process for the preparation of pyrroloquinoline quinone. US Patent 5344768; September 6, 1994.
65. D'Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003;12:639-643. (Pubitemid 38186756)
66. Watanabe A, Hobara N, Ohsawa T, et al. Nephrotoxicity of pyrroloquinoline quinone in rats. Hiroshima J Med Sci 1989;38:49-51.
67. Fluckiger R, Paz M, Mah J, et al. Characterization of the glycine-dependent redox-cycling activity in animal fluids and tissues using specific inhibitors and activators: evidence for presence of PQQ. Biochem Biophys Res Commun 1993;196:61-68. (Pubitemid 23309475)
68. Smidt CR, Unkefer CJ, Houck DR, Rucker RB. Intestinal absorption and tissue distribution of [14C] pyrroloquinoline quinone in mice. Proc Soc Exp Biol Med 1991;197:27-31.